Article
Partial reduction of BACE1 improves synaptic plasticity, recent and remote memories in Alzheimer's disease transgenic mice.
Journal of neurochemistry - 1 Apr 2010
Kimura Ryoichi, Devi Latha, Ohno Masuo
Abstract excerpt
beta-Site amyloid precursor protein cleaving enzyme 1 (BACE1) initiates amyloid-beta (Abeta) generation that is central to the pathophysiology of Alzheimer's disease (AD). Therefore, lowering Abeta levels by BACE1 manipulations represents a key therapeutic strategy, but it remains unclear whether partial inhibition of BACE1, as expected for AD treatments, can improve memory deficits. In this study, we used...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
